Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
NiSource
NI
$19.5B
| $2.42M | 0.06% |
81,933
+57,102
| +230% | +$1.73M |
|
427
KB Home
KBH
$3.39B
| $2.41M | 0.06% |
+84,820
| New | +$2.71M |
|
428
Halliburton
HAL
$29.4B
| $2.41M | 0.06% |
+76,782
| New | +$2.86M |
|
429
Clorox
CLX
$12.9B
| $2.4M | 0.06% |
17,015
+478
| +3% | +$68.3K |
|
430
FIVE9
FIVN
$2.45B
| $2.4M | 0.06% |
+26,297
| New | +$2.66M |
|
431
The Greenbrier Companies
GBX
$1.42B
| $2.4M | 0.06% |
66,562
+38,690
| +139% | +$1.62M |
|
432
Eagle Bancorp
EGBN
$861M
| $2.4M | 0.06% |
50,514
+44,812
| +786% | +$2.25M |
|
|
SJI
433
DELISTED
South Jersey Industries, Inc.
SJI
| $2.39M | 0.06% |
+70,017
| New | +$2.4M |
|
434
Portland General Electric
POR
$5.83B
| $2.39M | 0.06% |
49,397
-112,601
| -70% | -$5.6M |
|
435
iHeartMedia
IHRT
$432M
| $2.39M | 0.06% |
+302,397
| New | +$4.08M |
|
436
Lam Research
LRCX
$393B
| $2.38M | 0.06% |
55,940
-37,740
| -40% | -$1.8M |
|
437
Monster Beverage
MNST
$93.6B
| $2.38M | 0.06% |
102,812
-93,880
| -48% | -$2.04M |
|
|
SEM
438
DELISTED
Select Medical
SEM
| $2.38M | 0.06% |
186,903
-100,636
| -35% | -$1.29M |
|
439
Gibraltar Industries
ROCK
$1.38B
| $2.37M | 0.06% |
61,197
+48,406
| +378% | +$1.97M |
|
440
Ameriprise Financial
AMP
$49.1B
| $2.37M | 0.06% |
9,953
+4,653
| +88% | +$1.25M |
|
441
NVIDIA
NVDA
$5.2T
| $2.35M | 0.06% |
155,300
-34,230
| -18% | -$646K |
|
442
Cintas
CTAS
$81.6B
| $2.35M | 0.06% |
+25,168
| New | +$2.45M |
|
443
EPR Properties
EPR
$4.62B
| $2.35M | 0.06% |
+50,041
| New | +$2.54M |
|
|
AIMC
444
DELISTED
Altra Industrial Motion Corp
AIMC
| $2.34M | 0.06% |
66,420
-4,911
| -7% | -$183K |
|
445
Abercrombie & Fitch
ANF
$4.84B
| $2.33M | 0.06% |
+137,733
| New | +$3.8M |
|
|
PNTM
446
DELISTED
Pontem Corporation
PNTM
| $2.32M | 0.06% |
235,700
| – | – |
|
447
Old Republic International
ORI
$10B
| $2.31M | 0.06% |
103,385
-272,672
| -73% | -$6.31M |
|
448
Spire
SR
$4.78B
| $2.31M | 0.06% |
31,048
-51,577
| -62% | -$3.88M |
|
449
Lakeland Financial Corp
LKFN
$1.5B
| $2.3M | 0.06% |
34,627
+17,603
| +103% | +$1.26M |
|
|
AZEK
450
DELISTED
The AZEK Co
AZEK
| $2.29M | 0.06% |
137,078
+59,342
| +76% | +$1.22M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.